Y95B8A.12 gene of C. elegans encodes RhoGEF domain, which is a novel module in the Guanine nucleotide exchange factors (GEFs). Alternative splicing increases transcriptome and proteome diversification. Y95B8A.12 gene has two reported alternatively spliced transcripts by the C. elegans genome sequencing consortium. In the work presented here, we report the presence of four new spliced transcripts of Y95B8A.12 arising as a result of alternative splicing in the pre-mRNA encoded by Y95B8A.12 gene. Our methodology involved the use of various gene or exon finding programmes and several other bioinformatics tools followed by experimental validation. We have also studied alternative splicing pattern in RhoGEF domain encoding orthologues gene from C. briggsae and have obtained very similar results. These new unreported spliced transcripts, which were not detected through conventional approaches, not only point towards the extent of alternative splicing in C. elegans genes but also emphasize towards the need of analyzing genome data using a combinations of bioinformatics tools to delineate all possible gene products.
RhoGEF family is a widespread family found commonly in almost all organisms like Humans, Mouse, and Drosophila, C. elegans etc. In C. elegans this family consists of a large number of members and here the number of RhoGEF and RhoGAP regulators of Rho GTPases significantly exceeds the number of Rho family GTPases. These regulators likely provide the signaling specificity and spatial-temporal regulation required by the broadly expressed and functionally important Rho family GTPases. Alternative splicing has recently emerged as a major mechanism of generating protein diversity in higher eukaryotes including nematodes Caenorhabditis elegans. Recently, we successfully demonstrated identification of novel transcripts using a bioinformatics methodology involving both computational and experimental analysis in C. elegans. [15] Genefinder prediction by the C. elegans sequencing consortium of genomic sequence of Y95B8A.12 has reported two spliced transcripts Y95B8A.12a and Y95B8A.12b that arise as a result of alternative splicing alternative splicing of pre-mRNA in the intronic region between exon 2 and exon 3 of Y95B8A.12. Detailed analysis of Y95B8A.12 gene using a wide array of bioinformatics tools and programmes like gene/exon/ORF finding tools, BLAST analysis, sequence alignment programmes and many more; we predicted the existence of atleast four new 
Methodology: Nematode
The wild-type C. elegans strain, N2 (var. Bristol), and the attenuated E. coli strain was used as a food source in all experiments as described essentially in.
[16] All nematodes were cultured at 20°C on standard NGM agar (0.3 percent NaCl, 0.25 percent peptone, 5 mg per ml cholesterol, 1 mM CaCl 2 , 1 mM MgSO 4 , 1.7 percent agar) seeded with live Escherichia coli (OP50).
Chemicals
RevertAid™ M-MuLV Reverse Transcriptase and oligo (dT) 18 primer were purchased from Fermentas, Hanover, (USA), Taq DNA Polymerase and PCR-Buffer were purchased from Bangalore Genie Pvt. Ltd., India. dNTP Mix (2.5 mM each) and 1kb DNA ladder was purchased from MBI Fermentas, USA. All other chemicals used in the experiments were of molecular biology grade.
Primers used
The following oligonucleotides primers were custom synthesized from MWG Biotech, Pvt. Ltd., India.
(1) F1: 5' GCAGTTGTTCACCCCGTTGATTAG 3' (2) F2: 5' ACATACGAGGAAATCAATTGATTAAGCC 3' (3) F3: 5' CGGCAAGACTTCAGGATCGATGGAG 3' (4) R1: 5' TCCAGCTCATCATCCTCAATCTC 3' (5) R1: 5' AATAATCTCCCTCCGTTTTGCTCTGCCC 3' Total RNA Isolation Total RNA was isolated from mixed-stage nematodes using the method described earlier.
[17] Finally, total RNA was dissolved in diethyl pyrocarbonate-treated distilled water. The yield of RNA was determined spectrophotometrically, and the quality of the RNA was checked by gel electrophoresis. The resulting RNA was used for RT-PCR.
Reverse transcriptase (RT)-PCR
Computationally predicted transcripts encoding alternatively spliced exons were validated using RT-PCR. C. elegans total RNA (2 micro gram) was primed with oligo (dT) 18 and singlestranded cDNA was synthesized using the Revert Aid™ Reverse Transcriptase at 42 degree C for 60 min. (total vol. 20 micro liter). The target sequences were PCR amplified in 25 micro liter reaction volume. The program consisted of an initial denaturation step at 95 degree C for 5 min, followed by 30 cycles at 94 degree C for 1 min, 58 degree C for 1 min, and 72 degree C for 1 min. The program ended with a final elongation step at 72 degree C for 10 min. RT-PCR product (8 micro liter) obtained after 30 cycles were electrophoretically separated on a 2 percent agarose gel, stained with ethidiumbromide and photographed on a UV transilluminator.
Semi nested PCR
For further confirmation of results obtained after first round of PCR (for the presence of predicted spliced transcripts), semi nested PCR was performed. Here, after the first PCR amplification (as detailed above) the resulting RT-PCR product (2 micro liter) was used as a template for further amplification by PCR using the same forward but a new reverse primer (placed just internal to the reverse primer used in first PCR) specific for the same exon (as used in first PCR). The resulting semi nested PCR product (10 micro liter) was then subjected to electrophoresis on a 1 percent (weight by volume) agarose gel, stained with ethidium bromide and photographed on UV transilluminator. These new exons were predicted to encode 15 to 21 amino acids and had methionine as the initiation codon and each potentially able to splice into exon 2 as shown (Figure 1 and Tables 1 and 2 (under supplementary material)). As there were two already reported spliced transcripts and computational analysis had predicted two new N-terminal exons, so by combining the results we were able to predict four new alternatively spliced transcripts of the gene Y95B8A.12 namely Y95B8A.12c, Y95B8A.12d, Y95B8A.12e and Y95B8A.12f. All these new spliced transcripts arise due to alternative splicing of Y95B8A.12 premRNA in 5' untranslated region. In Y95B8A. Tables 1 and 2 (in  supplementary material) ). Since all these transcripts arise because of alternative splicing of non-coding exons, it may add further complexity to Y95B8A.12 gene regulation and working mechanism.
Tools used for Computational and Bioinformatic analysis
Following the computational predictions of new spliced transcripts, we searched the Yuji Kohara's C. elegans EST database to look for putative EST or cDNA support for possible occurrence of these new exons or transcripts. A search of Yuji Kohara's C. elegans EST database for EST match didn't yield any fruitful matches, which is expected keeping in mind the problems and limitations of the EST database. Moreover, the likelihood of observing ESTs for alternative splice forms in a gene correlates with increasing number of ESTs for that gene; it is highest for highly expressed genes and virtually nil for low-abundance genes. This may be the most possible reason to explain why Yuji Khoara's C. elegans expressed sequence tag (EST) database search for putative EST or cDNA support for possible occurrence of these new exons/transcripts failed. NCBI BLAST search was done to look for homology of these new spliced transcripts but no significant information could be obtained about the prospective similarity with other polypeptides. Consensuses splice signals that are not normally used as splice sites (known as "cryptic" splice sites) occur frequently in a given pre-mRNA. Generally, intronic sequences at splice junctions are highly conserved (99.24 percent of introns have a "GT-AG" at their 5' and 3' ends, respectively) in almost all eukaryotic species. [26, 27] The presence of consensus sequences at the splice-donor /acceptor site is believed to be a structural feature that determines whether a specific splice site is used although these consensus sequences may not be always present.
[27] Analysis of the exon-intron junction region of the newly predicted N-terminal exons of Y95B8A.12c, Y95B8A.12d, Y95B8A.12e and Y95B8A.12f indicates structural conservation, as depicted (Table 1 under supplementary material) . The presence of consensus sequences in the splice-donor /acceptor site provides the further confirmatory evidence for the existence of new N-terminal exons of Y95B8A.12c, Y95B8A.12d, Y95B8A.12e and Y95B8A.12f. After the failure in search for supporting EST or cDNA matches for our newly predicted transcripts, the next way to confirm our findings was to validate them using RT-PCR.
Experimental validation of computationally identified new spliced transcripts
RT-PCR amplification was used to validate the possible existence of new transcripts of Y95B8A.12 gene as predicted on the basis of computational analysis. Here, our aim was only to prove that what predictions we got from our computational analysis were genuine enough. So, we selected only 1 of the 2 (Y95B8A.12a) C. elegans Sequencing Group reported alternatively spliced transcripts of Y95B8A.12 gene for practical validation. Moreover, we were also unable to verify some of our predicted transcripts mainly Y95B8A.12e, Y95B8A.12f (arising form combination with Sanger's prediction i.e. 2nd control Y95B8A.12b) as there was only around 20-30 bp difference in the transcripts, which was difficult to resolve on gel. For e.g. In Y95B8A.12a, the third exon (24 bp), is spliced out to give rise to another spliced transcript named as Y95B8A.12b (Figure 1) . Briefly, for experimental confirmation of these spliced transcripts, total RNA, prepared from mixed-stage C. elegans, was reverse transcribed and the resulting single-stranded cDNA was PCR amplified (as detailed in materials and methods). Forward and Reverse primers used for the identification of splice transcripts were designed using a combination of bioinformatics tools and manual methods, so that they bind only to specific exon sequences. As a result, we would expect two reaction products, which are different in length if a splice event takes place. These exon specific primers were able to successfully validate the occurrence of the spliced transcripts by giving a band of anticipated size (Figure 2 ) when a particular primer pair specific to that particular exon was PCR amplified and products visualized on agarose gel, stained with ethidium bromide and photographed on a UV transilluminator. For transcripts of low abundance, for which the RT-PCR products could not be visualized after the procedure described above (as in case of predicted spliced transcripts Y95B8A.12d Figure 2 The goal of our work was to use a novel bioinformatics approach capable of complementing the conventional methods of identifying spliced transcripts by providing efficient delineation of all possible putative gene transcripts. Our findings emphasize towards the urgent need to analyze genome data using a combination of bioinformatics tools, programmes in order to delineate all possible gene products and to estimate the true extent of alternative splicing in C. elegans genes. It may also encourage other researchers to take up similar exhaustive studies in several other finished genomes especially of humans with whom C. elegans share a close gene homology. Moreover, further studies in this direction could be taken up which would enhance our knowledge about the biological and functional significance of these spliced transcripts and their possible role in RhoGEF gene working and regulation. Taking the above data and facts into consideration, we can easily say that N-terminal transcripts in both organisms arise due to alternative splicing of pre-mRNA in 5' untranslated region. The almost similar pattern of alternative splicing event indicates towards the evolutionarily conserved nature of alternative splicing in the two closely related genomes and its possible role in evolution of the two species. It may be that patterns of alternative splicing are conserved at similar levels to genes and gene structures. Thus, it can easily be hypothesized that many, and probably most, alternative splicing events are conserved between C. elegans and C. briggsae genomes. 
